CXCL12 ameliorates neutrophilia and disease severity in SARS-CoV-2 infection

Overview of attention for article published in Journal of Clinical Investigation, January 2025

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (58th percentile)

Mentioned by

twitter: 5 X users

bluesky: 1 Bluesky user

Readers on

mendeley: 6 Mendeley

So far, Altmetric has seen 7 X posts from 5 X users, with an upper bound of 19,515 followers.

4/7 #References: JCI - CXCL12 ameliorates neutrophilia and disease severity in SARS-CoV-2 infection https://t.co/NtEcPha1OG @iitmadras @iitmbt @IITMIC @iitbombay @IITBHU_Varanasi @iitgn @IITKanpur @iit__mandi @IITPAT @iiserkol @IISER_BERHAMPUR @IISERPun…

🧐 #neutrophils #COVID_19 #CXCL12 https://t.co/JIcwJYslMh

RT @jiapenghuang: Our Team Newest JCI Publication: #CXCL12 ameliorates neutrophilia and disease severity in #SARS-CoV-2 infection #neutrop…

#Sars https://t.co/stTt9y7Z3k

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 3 additional X posts.